PMID- 36578740
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230103
IS  - 1998-3611 (Electronic)
IS  - 0019-5154 (Print)
IS  - 0019-5154 (Linking)
VI  - 67
IP  - 4
DP  - 2022 Jul-Aug
TI  - A Joint Consensus of Rheumatologists and Dermatologists on Early Detection and 
      Effective Management of Psoriatic Arthritis: India's Perspective.
PG  - 479
LID - 10.4103/ijd.ijd_939_20 [doi]
AB  - Psoriatic arthritis (PsA) is a chronic inflammatory disease with clinical 
      manifestations, including inflammatory arthritis and the presence of psoriasis 
      (PsO). The present consensus statement evaluated the early diagnosis and 
      treatment approaches in the management of psoriasis and psoriatic arthritis by 
      rheumatologists and dermatologists. For PAN India representation, a panel of 
      eight rheumatologists and five dermatologists from different institutes in India 
      were constituted. These thirteen experts were divided into two groups 
      (rheumatologists group and dermatologist group) who received a set of 
      questionnaires each for diagnosis and treatment approaches in the management of 
      psoriasis and psoriatic arthritis. Based on the responses received, a panel 
      discussion took place, where the experts identified the early diagnostic criteria 
      for PsA considering: Clinical signs and symptoms, and questionnaire-based PsA 
      screening, which includes Psoriasis Epidemiology Screening Tool (PEST) for 
      dermatologists and Classification Criteria for Psoriatic Arthritis (CASPAR) for 
      rheumatologists. The experts also recommended shift from conventional 
      disease-modifying anti-rheumatic drugs (DMARDs) to biologics like secukinumab, 
      when there is extensive skin involvement and TNF inhibitors when there is 
      extensive joint involvement. Overall, the objective of the consensus was to 
      assist rheumatologists and dermatologists in the early diagnosis and management 
      of patients of PsA and PsO in their clinical practice.
CI  - Copyright: (c) 2022 Indian Journal of Dermatology.
FAU - Chatterjee, Manas
AU  - Chatterjee M
AD  - Command Hospital, Kolkata, West Bengal, India.
FAU - Nayak, Chitra
AU  - Nayak C
AD  - Nair Hospital, Mumbai, Maharashtra, India.
FAU - De, Abhishek
AU  - De A
AD  - Calcutta National Medical College, Kolkata, West Bengal, India.
FAU - Rajadhyaksha, Samir
AU  - Rajadhyaksha S
AD  - Global Hospital, Parel, Mumbai, Maharashtra, India.
FAU - Singh, G K
AU  - Singh GK
AD  - Base Hospital, Delhi, India.
FAU - Kumar, Phani
AU  - Kumar P
AD  - NIMS, Hyderabad, Telangana, India.
FAU - Balameena, S
AU  - Balameena S
AD  - Department of Rheumatology, Kilpauk Medical College, Chennai, Tamil Nadu, India.
FAU - Kumar, M Harish
AU  - Kumar MH
AD  - Department of Rheumatology, Command Hospital, Bangalore, Karnataka, India.
FAU - Hema, M
AU  - Hema M
AD  - Department of Rheumatology, Stanley Medical College, Chennai, Tamil Nadu, India.
FAU - Choudhury, Gautam Dhar
AU  - Choudhury GD
AD  - Department of Rheumatology and Clinical Immunology, Command Hospital (Eastern 
      Command), Alipore Road, Kolkata, West Bengal, India.
FAU - Pangtey, Ghan Shyam
AU  - Pangtey GS
AD  - LHMC, Delhi, India.
FAU - Singh, Jatinder
AU  - Singh J
AD  - AFMC, Pune, Maharashtra, India.
FAU - Jain, Neeraj
AU  - Jain N
AD  - Sir Ganga Ram Hospital, Delhi, India.
LA  - eng
PT  - Journal Article
PT  - Review
PL  - India
TA  - Indian J Dermatol
JT  - Indian journal of dermatology
JID - 0370750
PMC - PMC9792027
OTO - NOTNLM
OT  - Classification criteria for psoriatic arthritis
OT  - psoriasis epidemiology screening tool
OT  - psoriatic arthritis
COIS- There are no conflicts of interest.
EDAT- 2022/12/30 06:00
MHDA- 2022/12/30 06:01
PMCR- 2022/07/01
CRDT- 2022/12/29 02:33
PHST- 2022/12/29 02:33 [entrez]
PHST- 2022/12/30 06:00 [pubmed]
PHST- 2022/12/30 06:01 [medline]
PHST- 2022/07/01 00:00 [pmc-release]
AID - IJD-67-479d [pii]
AID - 10.4103/ijd.ijd_939_20 [doi]
PST - ppublish
SO  - Indian J Dermatol. 2022 Jul-Aug;67(4):479. doi: 10.4103/ijd.ijd_939_20.